Michael J. Sofia - Jan 20, 2022 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Chief Scientific Officer
Signature
/s/ David C. Hastings as attorney-in-fact for Michael J. Sofia
Stock symbol
ABUS
Transactions as of
Jan 20, 2022
Transactions value $
$800,850
Form type
4
Date filed
1/20/2022, 04:54 PM
Previous filing
Dec 3, 2021
Next filing
Feb 3, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Option (Right to Buy) Award $801K +285K $2.81 285K Jan 20, 2022 Common Shares 285K $2.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options will vest and become exercisable 1/48th each month over the four year period.